Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Italy Spain
  • Study of belumosudil in children aged 1 to 18 years with moderate to severe chronic graft versus host disease requiring systemic treatment

    Recruiting

    1 1
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Spain
  • A Study of Belumosudil for Patients with Steroid-Resistant Overlap Syndrome Graft-versus-Host Disease

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on Axatilimab and Corticosteroids for Initial Treatment of Chronic Graft-Versus-Host Disease in Patients

    Recruiting

    1 1 1
    Investigated diseases:
    Austria Denmark France Germany Ireland Italy +2
  • Study on Ruxolitinib and Methoxsalen for Patients with Steroid-Refractory Chronic Graft-versus-Host Disease

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany
  • Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Finland France Germany +8
  • Study of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Greece Italy Spain
  • Study on Axatilimab and Ruxolitinib for Patients with Newly Diagnosed Chronic Graft-Versus-Host Disease

    Not recruiting

    1 1 1
    Investigated diseases:
    Belgium Germany Italy Spain
  • Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

    Not recruiting

    1 1 1 1
    Germany Italy Poland Sweden
  • Study of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease

    Not recruiting

    1 1 1
    Investigated diseases:
    Austria Belgium Czechia Denmark France Germany +7